Skip to main content

Table 2 HDACis in clinical trials for leukemia

From: Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia

Chemical structure

Name

Target

Study phase

Hydroxamates

SAHA (vorinostat)

Pan-inhibitor

Phase I/II alone or in combination

PXD101 (belinostat)

Pan-inhibitor

Phase I/II alone or in combination

LBH589 (panobinostat)

Pan-inhibitor

Phase I/II alone or in combination

Cyclic peptides

Depsipeptide/FK228 (romidepsin)

Classes I

Phase I/II alone or in combination

Aliphatic fatty acids

Valproic acid

Classes I and IIa

Phase II alone or in combination

Butyrate

Pan-inhibitor

Phase I/II alone or in combination

Benzamides

MS-275 (entinostat)

Class I

Phase I alone or in combination

MGCD0103 (mocetinostat)

Class I/IV

Phase I alone or in combination

  1. HDACis HDAC inhibitors